ANIKA THERAPEUTICS INC (ANIK)
US0352551081 - Common Stock
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 72.87M | 86.30M | 94.40M | 95.80M | 157.50M | |||
| Marketable Securities | N/A | N/A | 0.00 | 2.50M | 27.50M | |||
| Receivables | 35.96M | 34.60M | 29.80M | 24.10M | 23.10M | |||
| Inventories | 46.39M | 39.80M | 36.00M | 46.20M | 22.00M | |||
| Other Current Assets | 8.10M | 8.80M | 8.30M | 8.80M | 4.30M | |||
| Total Current Assets | 163.31M | 169.50M | 168.50M | 177.40M | 234.30M | |||
| Non-Current Assets | ||||||||
| PPE Net | 74.97M | 79.00M | 68.60M | 73.20M | 73.60M | |||
| Goodwill | 7.57M | 7.30M | 7.80M | 8.40M | 7.70M | |||
| Intangibles | 4.63M | 74.60M | 82.40M | 91.20M | 7.60M | |||
| Other Non-Current Assets | 20.16M | 18.70M | 20.30M | 15.40M | 7.50M | |||
| Total Non-Current Assets | 107.32M | 179.60M | 179.00M | 188.20M | 96.40M | |||
| TOTAL ASSETS | 270.63M | 349.10M | 347.50M | 365.60M | 330.70M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | N/A | 0.00 | 200.00K | 100.00K | N/A | |||
| Accrued Expenses | 19.96M | 18.00M | 17.70M | 14.60M | 12.40M | |||
| Accounts Payable | 9.86M | 9.10M | 7.60M | 9.00M | 3.80M | |||
| Other Current Liabilities | 1.24M | 800.00K | 4.30M | 13.10M | N/A | |||
| Total Current Liabilities | 31.06M | 27.90M | 29.80M | 36.90M | 16.30M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Deferred Taxes/Income | 0.00 | 6.40M | 10.20M | 11.90M | 4.30M | |||
| Other Non-Current Liabilities | 27.31M | 29.20M | 20.50M | 44.40M | 21.70M | |||
| Total Non-Current Liabilities | 27.31M | 35.70M | 30.70M | 56.30M | 26.00M | |||
| TOTAL LIABILITIES | 58.37M | 63.60M | 60.50M | 93.20M | 42.30M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | 128.05M | 210.70M | 225.60M | 221.40M | 245.40M | |||
| Additional Paid In Capital | 90.01M | 81.10M | 67.10M | 55.40M | 48.70M | |||
| Common Shares | 147.00K | 100.00K | 100.00K | 100.00K | 100.00K | |||
| Other Shareholders' Equity | -5.94M | -6.40M | -5.70M | -4.50M | -5.90M | |||
| Shares Outstanding | 14.66M | 14.60M | 14.40M | 14.30M | 14.30M | |||
| Tangible Book Value per Share | 13.65 | 13.95 | 13.67 | 12.08 | 19.10 | |||
| Total Shareholders' Equity | 212.26M | 285.60M | 287.10M | 272.40M | 288.40M | |||
| TOTAL LIABILITIES AND EQUITY | 270.63M | 349.10M | 347.50M | 365.60M | 330.70M | |||
| Statistics | ||||||||
| Current Ratio | 5.26 | 6.08 | 5.65 | 4.81 | 14.37 | |||
| Return On Assets (ROA) | -30.55% | -4.27% | 1.18% | -6.56% | 8.22% | |||
| Return On Equity (ROE) | -38.95% | -5.22% | 1.43% | -8.81% | 9.43% | |||
| Return On Invested Capital (ROIC) | N/A | N/A | 0.65% | 3.41% | 8.59% | |||
| Return On Invested Capital Ex Cash (ROICexc) | N/A | N/A | 0.92% | 4.87% | 20.88% | |||
| Return On Invested Capital Ex Cash + Goodwill (ROICexcg) | N/A | N/A | 1.54% | 8.58% | 23.68% | |||
All data in USD